Night-time sedating H1 antihistamine increases daytime somnolence but not treatment efficacy in chronic spontaneous urticaria: A randomized controlled study

British Journal of Dermatology

Volumn 171, Issue 1, 2014, Pages 8-9

  Grattan, C ^a  

^a NORFOLK AND NORWICH UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; HYDROXYZINE; LEVOCETIRIZINE; HISTAMINE H1 RECEPTOR ANTAGONIST;

ALERTNESS; DAYTIME SOMNOLENCE; DRUG EFFICACY; HUMAN; NOTE; PRIORITY JOURNAL; QUALITY OF LIFE; SCORING SYSTEM; SLEEP QUALITY; TREATMENT RESPONSE; URTICARIA; CHEMICALLY INDUCED; FEMALE; MALE; SLEEP DISORDER;

FEMALE; HISTAMINE H1 ANTAGONISTS; HUMANS; HYDROXYZINE; MALE; SLEEP DISORDERS; URTICARIA;

EID: 84904872237     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/bjd.13112     Document Type: Note

References (4)

1. Staevska M, Gugutkova M, Lazarova C, et al,. Night-time sedating H1 antihistamine increases daytime somnolence but not treatment efficacy in chronic spontaneous urticaria: a randomized controlled study. Br J Dermatol 2014; 171: 148-54.
2. Staevska M, Popov TA, Kralimarkova T, et al,. The effectiveness of levocetirizine and desloratadine in up to 4 times conventional doses in difficult-to-treat urticaria. J Allergy Clin Immunol 2010; 125: 676-82.
3. Conen S, Theunissen EL, Van Oers AC, et al,. Acute and subchronic effects of bilastine (20 and 40 mg) and hydroxyzine (50 mg) on actual driving performance in healthy volunteers. J Psychopharmacol 2011; 25: 1517-23.
4. Zuberbier T, Asero R, Bendslev-Jensen C, et al,. EAACI/GA(2)LEN/EDF/WAO guideline: management of urticaria. Allergy 2009; 64: 1427-43.